Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Life's Essential 8 in Pregnancy and Time to Incident Cardiometabolic Disease Over 7 Years Follow-Up.

JAMA network open·2026
Same author

Diet and mycoestrogen exposure in a pregnancy cohort: the Jersey Babies pilot study.

Journal of exposure science & environmental epidemiology·2026
Same author

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

JACC. Advances·2026
Same author

Postpartum Dietary Interventions and Cardiometabolic Profiles After Pregnancies Complicated by Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis.

Diabetes care·2026
Same author

The Escalating Global Burden of motor neuron disease: spatiotemporal trends among older adults, affected factors, and future projections.

American journal of clinical and experimental immunology·2026
Same author

Associations of preconception retinal microvasculature with lipid profiles from mid-pregnancy to three months postpartum.

NPJ cardiovascular health·2026

Related Experiment Video

Updated: May 26, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

A Machine Learning Framework to Quantify Postprandial Glucose Responses in Gestational Diabetes.

Souptik Barua1, Tenzin Sangmo2, Dhairya Upadhyay1

  • 1Division of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.

Diabetes Technology and Obesity Medicine
|May 25, 2026
PubMed
Summary

A machine learning algorithm accurately identifies postprandial glucose responses (PPGR) using continuous glucose monitoring (CGM) data in pregnant individuals with gestational diabetes mellitus (GDM). This automated method offers a convenient approach to monitoring glucose levels.

Keywords:
Gestational diabetes mellituscontinuous glucose monitoringmachine learningpostprandial glucose response

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Experiment Videos

Last Updated: May 26, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Area of Science:

  • Endocrinology
  • Medical Informatics
  • Machine Learning

Background:

  • Gestational diabetes mellitus (GDM) requires careful glucose monitoring during pregnancy.
  • Continuous glucose monitoring (CGM) provides valuable data, but analysis can be time-consuming.
  • Automated methods are needed to efficiently interpret CGM data for GDM management.

Purpose of the Study:

  • To develop and validate a machine learning (ML) framework for automatic identification of postprandial glucose responses (PPGR) from CGM data.
  • To assess the accuracy of ML-identified PPGRs compared to those derived from self-reported mealtimes in pregnant adults with GDM.

Main Methods:

  • A random forest ML algorithm was employed to analyze CGM data from pregnant adults with GDM or impaired glucose tolerance (IGT).
  • Participants wore blinded CGMs and logged mealtimes.
  • The ML algorithm's performance was evaluated by comparing its predicted mealtimes and subsequent PPGRs against those based on self-reported meal data.

Main Results:

  • The ML algorithm demonstrated a median absolute error of 30 minutes in predicting mealtimes compared to self-reports.
  • Differences in 1-hour and 2-hour postprandial glucose responses between ML-predicted and self-reported mealtimes were minimal (median differences of 8.7 mg/dL and 3.3 mg/dL, respectively).

Conclusions:

  • A random forest ML algorithm effectively identifies PPGRs from CGM data in individuals with GDM.
  • This automated approach provides a convenient and accurate method for monitoring postprandial dysglycemia in this population.